{"pmid":32385954,"title":"Caring for people with heart failure and many other medical problems through and beyond the COVID-19 pandemic; the advantages of universal-access to home telemonitoring.","text":["Caring for people with heart failure and many other medical problems through and beyond the COVID-19 pandemic; the advantages of universal-access to home telemonitoring.","Eur J Heart Fail","Cleland, John Gf","Clark, Robyn A","Pellicori, Pierpaolo","Inglis, Sally C","32385954"],"journal":"Eur J Heart Fail","authors":["Cleland, John Gf","Clark, Robyn A","Pellicori, Pierpaolo","Inglis, Sally C"],"date":"2020-05-10T11:00:00Z","year":2020,"_id":"32385954","source":"PubMed","week":"202019|May 04 - May 10","doi":"10.1002/ejhf.1864","topics":["Prevention"],"weight":1,"_version_":1666340102074269696,"score":9.490897,"similar":[{"pmid":32405146,"pmcid":"PMC7217768","title":"Optimizing Access to Heart Failure Care in Canada during the COVID-19 Pandemic.","text":["Optimizing Access to Heart Failure Care in Canada during the COVID-19 Pandemic.","The traditional model of heart failure (HF) care in Canada, which relies upon a multi-disciplinary team and clinic based care processes, has been undermined as a result of the COVID-19 pandemic. As the pandemic continues, we will be challenged to improve or maintain the health status of those with HF by optimizing guideline-directed care despite physical distancing constraints and a reduction in the healthcare workforce. This will require development of new strategies specifically targeted at decreasing the risk of decompensation and resultant HF hospitalization. As such, we must quickly pivot to the adoption and application of novel technologies and revise usual care models, processes, and workflow. The unprecedented COVID-19 crisis has delivered the Canadian HF community a burning platform for the design and implementation of innovative approaches to support the vulnerable population we serve; born out of necessity, we now have the opportunity to explore innovative approaches that may inform the future of HF care delivery in Canada. Herein, we provide perspectives from leadership within the Canadian Heart Failure Society (CHFS) on how to optimize HF care during the COVID-19 pandemic.","Can J Cardiol","Virani, S A","Clarke, B","Ducharme, A","Ezekowitz, J A","Heckman, G A","McDonald, M","Mielniczuk, L M","Swiggum, E","Van Spall, H G C","Zieroth, S","32405146"],"abstract":["The traditional model of heart failure (HF) care in Canada, which relies upon a multi-disciplinary team and clinic based care processes, has been undermined as a result of the COVID-19 pandemic. As the pandemic continues, we will be challenged to improve or maintain the health status of those with HF by optimizing guideline-directed care despite physical distancing constraints and a reduction in the healthcare workforce. This will require development of new strategies specifically targeted at decreasing the risk of decompensation and resultant HF hospitalization. As such, we must quickly pivot to the adoption and application of novel technologies and revise usual care models, processes, and workflow. The unprecedented COVID-19 crisis has delivered the Canadian HF community a burning platform for the design and implementation of innovative approaches to support the vulnerable population we serve; born out of necessity, we now have the opportunity to explore innovative approaches that may inform the future of HF care delivery in Canada. Herein, we provide perspectives from leadership within the Canadian Heart Failure Society (CHFS) on how to optimize HF care during the COVID-19 pandemic."],"journal":"Can J Cardiol","authors":["Virani, S A","Clarke, B","Ducharme, A","Ezekowitz, J A","Heckman, G A","McDonald, M","Mielniczuk, L M","Swiggum, E","Van Spall, H G C","Zieroth, S"],"date":"2020-05-15T11:00:00Z","year":2020,"_id":"32405146","source":"PubMed","week":"202020|May 11 - May 17","doi":"10.1016/j.cjca.2020.05.009","locations":["Canada","Canadian","Canada","Canada"],"countries":["Canada"],"countries_codes":["CAN|Canada"],"topics":["Prevention"],"weight":1,"_version_":1666802845417996289,"score":59.182354},{"pmid":32463534,"title":"Heart failure management during COVID-19 outbreak in Italy. Telemedicine experience from a heart failure university tertiary referral centre.","text":["Heart failure management during COVID-19 outbreak in Italy. Telemedicine experience from a heart failure university tertiary referral centre.","Eur J Heart Fail","Salzano, Andrea","D'Assante, Roberta","Stagnaro, Francesca Maria","Valente, Valeria","Crisci, Giulia","Giardino, Federica","Arcopinto, Michele","Bossone, Eduardo","Marra, Alberto Maria","Cittadini, Antonio","32463534"],"journal":"Eur J Heart Fail","authors":["Salzano, Andrea","D'Assante, Roberta","Stagnaro, Francesca Maria","Valente, Valeria","Crisci, Giulia","Giardino, Federica","Arcopinto, Michele","Bossone, Eduardo","Marra, Alberto Maria","Cittadini, Antonio"],"date":"2020-05-29T11:00:00Z","year":2020,"_id":"32463534","source":"PubMed","week":"202022|May 25 - May 31","doi":"10.1002/ejhf.1911","keywords":["covid-19","heart failure","sars-cov-2","telemedicine, prognosis, outcomes"],"locations":["Italy"],"countries":["Italy"],"countries_codes":["ITA|Italy"],"topics":["Prevention"],"weight":1,"_version_":1668079521472970752,"score":55.26375},{"pmid":32490720,"title":"Telemedicine during Covid-19 pandemic: Advantage or critical issue?","text":["Telemedicine during Covid-19 pandemic: Advantage or critical issue?","Telemedicine offers a support to traditional medicine, delivering clinical services when distance is a critical factor. Although this tool does not replace a medical examination, during Covid-19 pandemic, it reduces the spread of infection and avoids the need for a patient's visit. It is useful in the management of chronic disorders or for patients undergoing palliative treatment. The University Hospital of Palermo has applied this in cases of chronic illness caring for patients who cannot stop their treatment, such as Department of Onco-Haematology, Internal Medicine, Dermatology, etc. The Department of Legal Medicine of Palermo, in particular, is also using telemedicine to manage medico-legal sudden natural death investigations and dealing with the Public Prosecutor's office of Palermo. Even after the Covid-19 emergency, telemedicine will be essential to streamline outpatient visits, while at the same time limiting costs, with significant benefits for the Italian National Public Health Service budget. In conclusion, telemedicine can offer a valuable support to the doctor's activity by streamlining and facilitating their work. In this sense, the Covid-19 pandemic represents a positive input for the acceleration and enhancement of these tools.","Med Leg J","Perrone, Giuseppe","Zerbo, Stefania","Bilotta, Clio","Malta, Ginevra","Argo, Antonella","32490720"],"abstract":["Telemedicine offers a support to traditional medicine, delivering clinical services when distance is a critical factor. Although this tool does not replace a medical examination, during Covid-19 pandemic, it reduces the spread of infection and avoids the need for a patient's visit. It is useful in the management of chronic disorders or for patients undergoing palliative treatment. The University Hospital of Palermo has applied this in cases of chronic illness caring for patients who cannot stop their treatment, such as Department of Onco-Haematology, Internal Medicine, Dermatology, etc. The Department of Legal Medicine of Palermo, in particular, is also using telemedicine to manage medico-legal sudden natural death investigations and dealing with the Public Prosecutor's office of Palermo. Even after the Covid-19 emergency, telemedicine will be essential to streamline outpatient visits, while at the same time limiting costs, with significant benefits for the Italian National Public Health Service budget. In conclusion, telemedicine can offer a valuable support to the doctor's activity by streamlining and facilitating their work. In this sense, the Covid-19 pandemic represents a positive input for the acceleration and enhancement of these tools."],"journal":"Med Leg J","authors":["Perrone, Giuseppe","Zerbo, Stefania","Bilotta, Clio","Malta, Ginevra","Argo, Antonella"],"date":"2020-06-04T11:00:00Z","year":2020,"_id":"32490720","source":"PubMed","week":"202023|Jun 01 - Jun 07","doi":"10.1177/0025817220926926","keywords":["covid-19","telemedicine","chronic illness management, challenges in healthcare","pandemic"],"locations":["Palermo"],"countries":["Italy"],"countries_codes":["ITA|Italy"],"topics":["Prevention"],"weight":1,"_version_":1668892169383968768,"score":48.88086},{"pmid":32440973,"title":"Adapting to the COVID-19 Pandemic: Continuing HIV Prevention Services for Adolescents Through Telemonitoring, Brazil.","text":["Adapting to the COVID-19 Pandemic: Continuing HIV Prevention Services for Adolescents Through Telemonitoring, Brazil.","AIDS Behav","Dourado, Ines","Magno, Laio","Soares, Fabiane","Massa, Paula","Nunn, Amy","Dalal, Shona","Grangeiro, Alexandre","32440973"],"journal":"AIDS Behav","authors":["Dourado, Ines","Magno, Laio","Soares, Fabiane","Massa, Paula","Nunn, Amy","Dalal, Shona","Grangeiro, Alexandre"],"date":"2020-05-23T11:00:00Z","year":2020,"_id":"32440973","source":"PubMed","week":"202021|May 18 - May 24","doi":"10.1007/s10461-020-02927-w","locations":["Telemonitoring","Brazil"],"countries":["Brazil"],"countries_codes":["BRA|Brazil"],"topics":["Prevention"],"weight":1,"_version_":1667535119531900929,"score":48.675396},{"pmid":32463543,"title":"Management of Heart Failure Patients with COVID-19. A Joint Position Paper of the Chinese Heart Failure Association & National Heart Failure Committee and the Heart Failure Association of the European Society of Cardiology.","text":["Management of Heart Failure Patients with COVID-19. A Joint Position Paper of the Chinese Heart Failure Association & National Heart Failure Committee and the Heart Failure Association of the European Society of Cardiology.","The Coronavirus Disease 2019 (COVID-19) pandemic of severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) infection is causing considerable morbidity and mortality worldwide. Multiple reports have suggested that patients with heart failure (HF) are at a higher risk of severe disease and mortality with COVID-19. Moreover, evaluating and treating HF patients with comorbid COVID-19 represents a formidable clinical challenge as symptoms of both conditions may overlap and they may potentiate each other. Limited data exist regarding comprehensive management of HF patients with concomitant COVID-19. Since these issues pose serious new challenges for clinicians worldwide, HF specialists must develop a structured approach to the care of patients with COVID-19 and be included early in the care of these patients. Therefore, the Heart Failure Association of the European Society of Cardiology and Chinese Heart Failure Association & National Heart Failure Committee conducted web-based meetings to discuss these unique clinical challenges and reach a consensus opinion to help providers worldwide deliver better patient care. The main objective of this position paper is to outline the management of HF patients with concomitant COVID-19 based on the available data and personal experiences of physicians from Asia, Europe and United States. This article is protected by copyright. All rights reserved.","Eur J Heart Fail","Zhang, Yuhui","Stewart Coats, Andrew J","Zheng, Zhe","Adamo, Marianna","Ambrosio, Giuseppe","Anker, Stefan D","Butler, Javed","Xu, Dingli","Mao, Jingyuan","Khan, Muhammad Shahzeb","Bai, Ling","Mebazaa, Alexandre","Ponikowski, Piotr","Tang, Qizhu","Ruschitzka, Frank","Seferovic, Petar","Tschope, Carsten","Zhang, Shuyang","Gao, Chuanyu","Zhou, Shenghua","Senni, Michele","Zhang, Jian","Metra, Marco","32463543"],"abstract":["The Coronavirus Disease 2019 (COVID-19) pandemic of severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) infection is causing considerable morbidity and mortality worldwide. Multiple reports have suggested that patients with heart failure (HF) are at a higher risk of severe disease and mortality with COVID-19. Moreover, evaluating and treating HF patients with comorbid COVID-19 represents a formidable clinical challenge as symptoms of both conditions may overlap and they may potentiate each other. Limited data exist regarding comprehensive management of HF patients with concomitant COVID-19. Since these issues pose serious new challenges for clinicians worldwide, HF specialists must develop a structured approach to the care of patients with COVID-19 and be included early in the care of these patients. Therefore, the Heart Failure Association of the European Society of Cardiology and Chinese Heart Failure Association & National Heart Failure Committee conducted web-based meetings to discuss these unique clinical challenges and reach a consensus opinion to help providers worldwide deliver better patient care. The main objective of this position paper is to outline the management of HF patients with concomitant COVID-19 based on the available data and personal experiences of physicians from Asia, Europe and United States. This article is protected by copyright. All rights reserved."],"journal":"Eur J Heart Fail","authors":["Zhang, Yuhui","Stewart Coats, Andrew J","Zheng, Zhe","Adamo, Marianna","Ambrosio, Giuseppe","Anker, Stefan D","Butler, Javed","Xu, Dingli","Mao, Jingyuan","Khan, Muhammad Shahzeb","Bai, Ling","Mebazaa, Alexandre","Ponikowski, Piotr","Tang, Qizhu","Ruschitzka, Frank","Seferovic, Petar","Tschope, Carsten","Zhang, Shuyang","Gao, Chuanyu","Zhou, Shenghua","Senni, Michele","Zhang, Jian","Metra, Marco"],"date":"2020-05-29T11:00:00Z","year":2020,"_id":"32463543","source":"PubMed","week":"202022|May 25 - May 31","doi":"10.1002/ejhf.1915","keywords":["covid-19","coronavirus","diagnosis","heart failure","management","sars-cov2"],"locations":["United States"],"countries":["United States"],"countries_codes":["USA|United States"],"topics":["Prevention","Treatment"],"weight":1,"_version_":1668079521470873600,"score":46.98818}]}